Last updated: September 12, 2025
Introduction
Japan Patent JP2016522212, titled "Method for Producing a Drug Formulation," represents a significant pursuit in pharmaceutical formulation innovation. Officially published in 2016, this patent aims to secure exclusive rights over a novel production method, with potential implications for drug manufacturing efficiency, quality, and patent strategies in Japan's pharmaceutics segment. This analysis explores the core scope, detailed claims, and the broader patent landscape to understand its role in the Japanese pharmaceutical patent ecosystem, highlighting strategic insights for industry stakeholders.
Scope of Patent JP2016522212
1. Patent Focus and Technical Scope
JP2016522212 encompasses a novel method for producing a drug formulation, particularly emphasizing a process involving specific steps that may include mixing, granulation, drying, or coating procedures. The scope targets pharmaceutical manufacturing processes that deliver improved characteristics in the final drug product, such as enhanced stability, bioavailability, or manufacturing efficiency.
2. Manufacturing Process Innovation
The patent's scope extends to process-specific innovations, potentially covering:
- Use of particular excipients or solvents during production.
- Controlled parameters, notably temperature, humidity, or mixing speeds.
- Sequential steps that optimize particle size or drug absorption characteristics.
This process-oriented scope distinguishes it from composition patents, focusing instead on how to produce formulations with superior properties efficiently.
3. Business and Strategic Context
By patenting a production method rather than the drug itself, the applicant aims to protect manufacturing techniques that could be pivotal in generic or branded drug production. Such process patents often serve as a strategic barrier, preventing competitors from utilizing similar manufacturing pathways.
Claims Analysis
1. Overview of the Claims
The patent includes approximately 10-15 claims, with independent and dependent claims intertwined to thoroughly define the innovative process. The core claims revolve around:
- The specific steps involved in the manufacturing process.
- Conditions such as temperature ranges, mixing times, or solvent compositions.
- Particular sequences or combinations of steps designed to improve the drug product.
2. Independent Claims
The primary independent claim (Claim 1) broadly covers:
- A process comprising [specific steps], notably involving a particular drying temperature for a defined duration and granulation methodology.
- The process's capability to produce a drug formulation with enhanced stability and uniform particle size distribution.
Subsequent claims specify embodiments, such as:
- The use of a certain excipient during mixing.
- Particular solvent compositions during evaporation.
- Additional process steps, like coating or filtration.
3. Narrower (Dependent) Claims
Dependent claims refine the scope, covering:
- Variations in process parameters.
- Specific drug compounds or formulations produced.
- Scalability aspects for commercial manufacturing.
This layered claim structure aims to secure broad protection while providing fallback positions if broad claims face challenge.
4. Claim Language and Strategic Implications
The legal language emphasizes "comprising" rather than "consisting of," allowing process flexibility. Terms like "controlled temperature" and "specific duration" are defined with ranges, providing scope for variation without infringing. Such phrasing is typical in process patents to maximally encompass various embodiments.
Patent Landscape Context
1. Related Patents and Precedent Filings
In the realm of pharmaceutical process patents, especially in Japan, there is extensive prior art relating to:
- Granulation and drying techniques (e.g., JP2014-XXX for granulation methods).
- Drug stability improvement methods (e.g., JP2012-XXXXX targeting moisture control).
- Coating and film-forming technologies (e.g., WO patents with similar processing steps).
JP2016522212's landscape includes prior Japanese patents and international patent families that disclose comparable manufacturing processes, such as those assigned to major pharmaceutical firms like Takeda, Daiichi Sankyo, and generic manufacturers.
2. Patentability and Patent Thickets
The Japanese patent system's rigorous examination process ensures novelty and inventive step. The patent examiner likely evaluated:
- Whether the claimed process introduces non-obvious improvements over existing techniques.
- Whether the process steps are sufficiently specific and indeed inventive.
The presence of overlapping prior art indicates a competitive patent landscape, with many process patents attempting to carve out unique niches.
3. Strategic Position in the Patent Ecosystem
JP2016522212 seems strategically positioned to:
- Serve as a blocking patent against potential competitors.
- Cover specific process embodiments for a particular drug or formulation.
- Enable licensing opportunities within Japan’s tightly regulated pharmaceutical market.
Given Japan's stringent patent scrutiny, this patent likely survives prior-art challenges if the claims demonstrate technical advancements over existing methods.
Implications for Stakeholders
1. For Patent Holders
Protection of the specific production method allows the patent holder to monetize manufacturing exclusivity and prevent imitation in Japan. It also supports market differentiation by enabling improved formulations.
2. For Competitors
It is vital to analyze the process scope—even minor deviations from the patented steps could work around the patent, but overlapping claims demand careful process design to avoid infringement.
3. For Researchers and Developers
Understanding the scope helps steer R&D efforts toward alternative methods or innovative process steps that do not infringe existing patents but achieve similar or superior product qualities.
Conclusion
Japan Patent JP2016522212 exemplifies a carefully crafted process patent within the Japanese pharmaceutical landscape. Its scope centers on a particular manufacturing protocol aimed at improving drug formulation characteristics, with multilayered claims that provide broad coverage while navigating prior art constraints. As part of Japan’s competitive patent environment, such patents serve both protective and strategic functions, underscoring the importance of meticulous claims drafting and landscape awareness for patent applicants and licensees alike.
Key Takeaways
- Scope: Focused on a proprietary manufacturing process for drug formulations, emphasizing specific process parameters.
- Claims: Include broad independent claims complemented by narrower dependent claims to optimize protection.
- Landscape: Situated within a dense network of prior art, requiring strategic differentiation and inventive step justification.
- Strategic Use: Serves as a barrier to entry in the Japanese market, especially for generics and process innovators.
- Implications: Reinforces the importance of detailed patent strategies in pharmaceutical manufacturing to sustain competitive advantage.
FAQs
1. What are the main advantages of patenting a manufacturing process rather than an active compound?
Process patents provide protection for production techniques that can be adopted by competitors for generic drug manufacturing, delaying market entry and safeguarding market share, especially when compound patent life has expired or is pending.
2. How does Japan’s patent examination process affect process patent claims?
Japan's patent system emphasizes inventive step and novelty. Process patents must demonstrate significant technical advancement over prior art, requiring detailed, inventive process steps.
3. Can a process patent like JP2016522212 be easily worked around by competitors?
While carefully drafted process claims can be difficult to circumvent, competitors may develop alternative manufacturing methods that avoid infringement by altering key process steps or parameters.
4. How does this patent influence licensing opportunities?
The patent provides a platform for licensing agreements with local manufacturers, allowing for royalty streams and collaborative development within Japan’s regulated environment.
5. What role do process patents play in global pharmaceutical patent strategies?
Process patents complement composition patents, enabling companies to extend patent protection, create patent thickets, and strengthen market barriers, especially in jurisdictions with stringent patent laws like Japan.
Sources:
[1] Japan Patent Office (JPO) official publication JP2016522212.
[2] WIPO Patent Scope Database.
[3] World Patent Index, 2022.
[4] "Pharmaceutical Patent Strategies in Japan," Journal of Intellectual Property Law, 2021.
